{"title":"Isolation of four new phenolic compounds from the fungus Talaromyces cellulolyticus","authors":"Zhijun Song , Dawei Chen , Jungui Dai","doi":"10.1016/j.phytol.2024.09.003","DOIUrl":null,"url":null,"abstract":"<div><div>Four new phenolic compounds talarocelic A–D (<strong>1</strong>–<strong>4</strong>), together with four known compounds (<strong>5</strong>–<strong>8</strong>) were isolated from the fungus <em>Talaromyces cellulolyticus</em> CBS136886. Their chemical structures were elucidated through extensive spectroscopic data analysis such as HR-ESI-MS, UV, IR, and 1D- and 2D-NMR. Biological assay results revealed that compound <strong>6</strong> displayed potent protein tyrosine phosphatase 1B and <em>α</em>-glucosidase inhibitory activities with inhibition rates of 91.7 % and 59.6 %, respectively, at 10 μM. In addition, compound <strong>6</strong> showed moderate anti-inflammatory activity with 56.4 % inhibition at 10 μM and anti-bacterial activity against <em>Staphylococcus aureus</em> with a minimum inhibitory concentration of 12.5 μg/mL. This work not only reveals that <em>T. cellulolyticus</em> is rich in phenolic compounds but also provides access to diverse bioactive lead compounds for drug discovery.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"64 ","pages":"Pages 19-24"},"PeriodicalIF":1.3000,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390024001332","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Four new phenolic compounds talarocelic A–D (1–4), together with four known compounds (5–8) were isolated from the fungus Talaromyces cellulolyticus CBS136886. Their chemical structures were elucidated through extensive spectroscopic data analysis such as HR-ESI-MS, UV, IR, and 1D- and 2D-NMR. Biological assay results revealed that compound 6 displayed potent protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities with inhibition rates of 91.7 % and 59.6 %, respectively, at 10 μM. In addition, compound 6 showed moderate anti-inflammatory activity with 56.4 % inhibition at 10 μM and anti-bacterial activity against Staphylococcus aureus with a minimum inhibitory concentration of 12.5 μg/mL. This work not only reveals that T. cellulolyticus is rich in phenolic compounds but also provides access to diverse bioactive lead compounds for drug discovery.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.